By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Swiss distribution company Bucher Biotec will sell and service Denator's heat inactivation technology, used in handling biosamples, in Switzerland under an exclusive agreement, Denator said today.

Denator's Stabilizor T1 technology is used to stabilize tissues and fluids from the moment the sample is taken, and to keep enzymes from degrading.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.